/MET
MET Stock - MetLife, Inc.
Financial Services|Insurance - LifeNYSE
$81.57-0.18%
$0.14 (-0.18%) • Dec 19
76
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.BUY
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.62
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).93
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.90
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+21.7%upside
Target: $99.27
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for MET
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$80.75 – $82.39
TARGET (TP)$99.25
STOP LOSS$75.04
RISK/REWARD1:2.7
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.76
52W High$88.09
52W Low$65.21
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $69.94B | $67.71B | $67.97B | $63.37B | $67.89B |
| Gross Profit | $19.00B | $17.29B | $18.94B | $16.84B | $15.47B |
| Gross Margin | 27.2% | 25.5% | 27.9% | 26.6% | 22.8% |
| Operating Income | $5.62B | $2.16B | $6.36B | $8.52B | $6.93B |
| Net Income | $4.43B | $1.58B | $5.28B | $6.86B | $5.41B |
| Net Margin | 6.3% | 2.3% | 7.8% | 10.8% | 8.0% |
| EPS | $5.98 | $1.82 | $6.35 | $7.70 | $5.72 |
Company Overview
MetLife, Inc., a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements. It also provides pension risk transfers, institutional income annuities, structured settlements, and capital markets investment products; and other products and services, such as life insurance products and funding agreements for funding postretirement benefits, as well as company, bank, or trust-owned life insurance used to finance nonqualified benefit programs for executives. In addition, it provides fixed, indexed-linked, and variable annuities; and pension products; regular savings products; whole and term life, endowments, universal and variable life, and group life products; longevity reinsurance solutions; credit insurance products; and protection against long-term health care services. MetLife, Inc. was founded in 1863 and is headquartered in New York, New York.
Visit WebsiteRating Distribution
Strong Buy
0%
Buy / Outperform
7
64%
Hold / Neutral
4
36%
Sell / Underperform
0%
Analyst Consensus🟡 Mixed
7 Bullish4 Neutral/Bearish
Price Targets
$84
Average Target
↑ 2.5% Upside
Now
$71
Low
$84
Average
$101
High
Based on 14 analysts
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| December 16th 2025 | Mizuho | Initiation | Outperform | $101 |
| September 19th 2025 | Piper Sandler | Downgrade | Neutral | $84 |
| September 16th 2025 | Wolfe Research | Initiation | Outperform | $95 |
| January 23rd 2025 | BMO Capital Markets | Initiation | Market Perform | $97 |
| October 9th 2024 | TD Cowen | Initiation | Buy | $97 |
| September 5th 2024 | Barclays | Initiation | Overweight | $91 |
| January 8th 2024 | Goldman | Upgrade | Buy | $80 |
| November 17th 2023 | Barclays | Resumed | Overweight | $71 |
| October 5th 2023 | Deutsche Bank | Initiation | Hold | $71 |
| September 14th 2023 | Jefferies | Upgrade | Buy | $72← $58 |
| January 9th 2023 | Goldman | Downgrade | Neutral | $78← $80 |
| December 9th 2022 | Jefferies | Downgrade | Hold | $82← $86 |
| September 22nd 2022 | Raymond James | Initiation | Market Perform | - |
| June 23rd 2022 | Wolfe Research | Upgrade | Outperform | $74← $70 |
| May 24th 2022 | Citigroup | Initiation | Buy | $77 |
Earnings History & Surprises
METBeat Rate
56%
Last 18 quarters
Avg Surprise
+9.8%
EPS vs Estimate
Beats / Misses
10/8
Last 12 quarters
Latest EPS
$2.34
Q4 2025
EPS Surprise History
Q1 24
+2.7%
$1.93vs$1.88
Q2 24
-0.5%
$1.83vs$1.84
Q3 24
+8.6%
$2.28vs$2.10
Q4 24
-10.1%
$1.95vs$2.17
Q1 25
-1.4%
$2.08vs$2.11
Q2 25
-2.0%
$1.96vs$2.00
Q3 25
-6.0%
$2.02vs$2.15
Q4 25
+1.3%
$2.34vs$2.31
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | Apr 28, 2026 | — | — | — | — |
Q1 2026 | Feb 4, 2026 | $2.37 | — | — | — |
Q4 2025 | Nov 5, 2025 | $2.31 | $2.34 | +1.3% | ✓ BEAT |
Q3 2025 | Aug 6, 2025 | $2.15 | $2.02 | -6.0% | ✗ MISS |
Q2 2025 | Apr 30, 2025 | $2.00 | $1.96 | -2.0% | ✗ MISS |
Q1 2025 | Feb 5, 2025 | $2.11 | $2.08 | -1.4% | ✗ MISS |
Q4 2024 | Oct 30, 2024 | $2.17 | $1.95 | -10.1% | ✗ MISS |
Q3 2024 | Jul 31, 2024 | $2.10 | $2.28 | +8.6% | ✓ BEAT |
Q2 2024 | May 1, 2024 | $1.84 | $1.83 | -0.5% | ✗ MISS |
Q1 2024 | Jan 31, 2024 | $1.88 | $1.93 | +2.7% | ✓ BEAT |
Q4 2023 | Nov 1, 2023 | $1.99 | $1.97 | -1.0% | ✗ MISS |
Q3 2023 | Aug 2, 2023 | $1.85 | $1.94 | +4.9% | ✓ BEAT |
Q2 2023 | May 3, 2023 | $1.85 | $1.52 | -17.8% | ✗ MISS |
Q1 2023 | Feb 1, 2023 | $1.65 | $1.55 | -6.1% | ✗ MISS |
Q4 2022 | Nov 2, 2022 | $1.17 | $1.21 | +3.4% | ✓ BEAT |
Q3 2022 | Aug 3, 2022 | $1.55 | $2.00 | +29.0% | ✓ BEAT |
Q2 2022 | May 4, 2022 | $1.63 | $2.08 | +27.6% | ✓ BEAT |
Q1 2022 | Feb 2, 2022 | $1.42 | $2.17 | +52.8% | ✓ BEAT |
Q4 2021 | Nov 3, 2021 | $1.66 | $2.39 | +44.0% | ✓ BEAT |
Q3 2021 | Aug 4, 2021 | $1.61 | $2.37 | +47.2% | ✓ BEAT |
Latest News
MetLife Pet Insurance Collaborates With Petstablished To Offer Pet Insurance Quotes Directly Within The Adoption And Registration Process On The Petstablished Platform
📈 PositiveBenzinga•Dec 17, 2025, 02:44 PM
Mizuho Initiates Coverage On MetLife with Outperform Rating, Announces Price Target of $101
📈 PositiveBenzinga•Dec 16, 2025, 01:17 PM
Shares of stocks in the broader financial sector are trading higher amid overall market strength following the Fed's rate cut announcement.
📈 PositiveBenzinga•Dec 10, 2025, 08:41 PM•Also: , ,
Shares of banks and financial services stocks are trading higher after NY Fed President Williams indicated he sees room for a further policy adjustment in the near term. This has lifted overall market sentiment.
📈 PositiveBenzinga•Nov 21, 2025, 06:35 PM•Also: , ,
Keefe, Bruyette & Woods Maintains Outperform on MetLife, Lowers Price Target to $90
➖ NeutralBenzinga•Nov 11, 2025, 06:24 PM
Wells Fargo Maintains Overweight on MetLife, Lowers Price Target to $92
➖ NeutralBenzinga•Nov 7, 2025, 06:39 PM
UBS Maintains Buy on MetLife, Lowers Price Target to $95
➖ NeutralBenzinga•Nov 6, 2025, 06:47 PM
MetLife shares are trading lower after the company reported mixed Q3 financial results.
📉 NegativeBenzinga•Nov 6, 2025, 04:14 PM
MetLife Q3 Adj. EPS $2.37 Beats $2.32 Estimate, Sales $17.901B Miss $18.813B Estimate
➖ NeutralBenzinga•Nov 5, 2025, 09:28 PM
Wells Fargo Maintains Overweight on MetLife, Raises Price Target to $96
📈 PositiveBenzinga•Oct 8, 2025, 02:17 PM
Morgan Stanley Maintains Overweight on MetLife, Raises Price Target to $97
📈 PositiveBenzinga•Oct 7, 2025, 03:30 PM
Reported Saturday, MetLife And Global Citizen Announce Three Year Partnership With MetLife Foundation Committing $9M To FIFA Global Citizen Education Fund
📈 PositiveBenzinga•Sep 29, 2025, 06:50 AM
Piper Sandler Downgrades MetLife to Neutral, Maintains Price Target to $84
➖ NeutralBenzinga•Sep 19, 2025, 01:18 PM
Wolfe Research Initiates Coverage On MetLife with Outperform Rating, Announces Price Target of $95
📈 PositiveBenzinga•Sep 16, 2025, 11:26 AM
MetLife Urges Shareholders To Reject Unsolicited Mini-Tender Offer From Potemkin Of $53.00/Share
📉 NegativeBenzinga•Sep 15, 2025, 08:17 PM
Shares of banking and broader financial services stocks are trading higher amid overall market strength after Fed Chair Powell said restrictive policy and shifting risks may warrant adjusting the Fed's stance.
📈 PositiveBenzinga•Aug 22, 2025, 03:51 PM•Also: , ,
Morgan Stanley Maintains Overweight on MetLife, Lowers Price Target to $94
➖ NeutralBenzinga•Aug 18, 2025, 01:35 PM
Frequently Asked Questions about MET
What is MET's current stock price?
MetLife, Inc. (MET) is currently trading at $81.57 per share. The stock has moved -0.18% today.
What is the analyst price target for MET?
The average analyst price target for MET is $99.25, based on 1 analyst.
What sector is MetLife, Inc. in?
MetLife, Inc. operates in the Financial Services sector, specifically within the Insurance - Life industry. The company is traded on the NYSE exchange.
What is MET's market cap?
MetLife, Inc. has a market capitalization of $53.75 billion, making it a large-cap company.
Does MET pay dividends?
No, MetLife, Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Financial Services SectorAFL
Aflac Incorporated
$110.36
Mkt Cap: $59.7B
BHFAP
Brighthouse Financial, Inc.
$15.27
Mkt Cap: $2.5B
CNO
CNO Financial Group, Inc.
$43.55
Mkt Cap: $4.2B
GL
Globe Life Inc.
$139.64
Mkt Cap: $11.1B
JXN
Jackson Financial Inc.
$107.69
Mkt Cap: $7.3B
LNC
Lincoln National Corporation
$46.21
Mkt Cap: $8.8B
MFC
Manulife Financial Corporation
$36.16
Mkt Cap: $60.9B
PRU
Prudential Financial, Inc.
$114.99
Mkt Cap: $40.6B
PUK
Prudential plc
$30.84
Mkt Cap: $40.2B
UNM
Unum Group
$79.24
Mkt Cap: $13.3B
Explore stocks similar to MET for comparison